3 results
In this study, we will investigate how quickly and to what extent CKD 506 is absorbed, transported, and eliminated from the body. In addition, we will evaluate a possible interaction between CKD 506 and midazolam. We will do this by investigating…
The purpose of this study is to determine whether the efficacy and safetyof QVA149 (110/50 *g o.d.) and triple treatment with tiotropium (18 *go.d.) + salmeterol/fluticasone propionate FDC (50/500 *g b.i.d.) arecomparable in patients with moderate…
Primary objective:To determine the safety and tolerability of multiple doses of MOR103 in patients with active rheumatoid arthritis, at ascending dose levels.Secondary objectives:- to evaluate signs of efficacy of MOR103 in patients with active…